Scientific Program Peer Evaluations

The American Society of Hematology (ASH) is committed to providing high-quality, objective, balanced, scientifically rigorous activities that are free from bias. Efforts have been made to ensure that information presented at this meeting meets these standards. Real-time, peer evaluation of these sessions is intended to validate safeguards already in place and document deviations from the educational planning criteria for continuing medical education activities set by the Accreditation Council for Continuing Medical Education and ASH’s Conflict-of-Interest Policy (if applicable). It is also intended to assess the quality of the science presented in the ASH annual meeting. ASH appreciates your assistance with the peer evaluation process.

Please select the session below that you would like to peer review.

Scientific Program Sessions

• Ad Hoc Scientific Committee on Epigenetics and Genomics
  • Chromatin Structure in Development and Disease
• Joint Session: Scientific Committee on Bone Marrow Failure & Scientific Committee on Blood Disorders in Childhood
  • Molecular Mechanisms of Bone Marrow Failure
• Joint Session: Scientific Committee on Hematopathology and Clinical Laboratory Hematology & Scientific Committee on Stem Cells and Regenerative Medicine
  • Insights into Hematopoietic Stem Cell Origin, Differentiation and Malignancy Provided by Single Cell Approaches
• Scientific Committee on Hematopoiesis
  • Dynamic Change of the Hematopoietic Stem Cell Niche
• Scientific Committee on Hemostasis
  • Blood Coagulation: From Structure and Function to Therapeutics
• Scientific Committee on Immunology and Host Defense
  • Stromal Cell Immune Regulation in the Microenvironment
• Scientific Committee on Iron and Heme
  • Pumping Iron, Handling Heme: Forging New Links in Health and Disease
• Scientific Committee on Lymphoid Neoplasia
  • Hodgkin Lymphoma: Genes to Microenvironment to Immunotherapy
• Scientific Committee on Megakaryocytes and Platelets
  • Filling a Clinical Void: Engineering Platelets In Vitro
• Scientific Committee on Myeloid Biology
  • My Metabolism and Myelopoiesis
• Scientific Committee on Myeloid Neoplasia
  • Understanding and Targeting TP53 in Myeloid Malignancies
• Scientific Committee on Plasma Cell Neoplasia
  • Targeting Apoptosis in Myeloma
• Scientific Committee on Red Cell Biology
  • From Blood to Single Cells: Emerging Concepts and Technologies
• Scientific Committee on Thrombosis and Vascular Biology
  • Hemolytic Disorders and Thrombosis: Mechanistic and Clinical Insights
• Scientific Committee on Transfusion Medicine
  • Ex Vivo Bioengineering of Blood Products for Transfusion
• Scientific Committee on Transplantation Biology and Cellular Therapies
  • Genome Editing for Transplantation and Cellular Therapies

Special Scientific Symposia

• Changing the Taxonomy of Aggressive Lymphoma: Ready to Impact Clinical Management?
• Drugging the Undruggable
• Lost in Translation: Overcoming Roadblocks in Translating New Therapeutics to the Clinic
• Machine Learning in Hematology
• Special Symposium on the Basic Science of Hemostasis and Thrombosis

Scientific Spotlight Sessions

• Redox Biology in Thrombosis

Friday Scientific Workshops

• Interplay Between Coagulation and Malignancy
• Hematology and Aging: From Bleeding Disorders to Malignant Hematology
• Germline Predisposition to Hematopoietic Malignancies and Bone Marrow Failure
• Novel Curative Options: Gene-Editing and Gene Therapy for Hemoglobinopathies with a Focus on Sickle Cell Disease
• Innovation in Clinical Trial Design
• Integrative Epidemiology: Translating Epidemiology and Basic Science to Maximize Clinical Impact
• Tumor Immune Interactions in Lymphoid Malignancies
• Myeloid Development
• Immune Profiling and Minimal Residual Disease Testing in Multiple Myeloma